Bioactivx
Singapore, Singapore
◆ Total Raised
$3M
◆ Stage
seed
◆ Location
Singapore, Singapore
◆ Founded
2023
◆ Team size
1-10
◆ Links
◆ About Bioactivx
Singaporean biomaterial platform that makes synthetic skin substitutes for safer, faster, and scar-free wound healing.
◆ What sets it apart
A fully synthetic, bio-inspired skin substitute that avoids animal-derived materials and cold-chain dependence while aiming to reduce infection risk and scarring.
◆ Sectors
◆ Business
Modelhardware
CustomerHospitals, clinicians, wound-care providers, and healthcare systems treating burns, ulcers, surgical wounds, and trauma patients
◆ Notable
- Founded in 2023 as an A*STAR spin-off
- Raised a US$1.425M seed round
- Raised a US$3M pre-Series A round
- Submitted a full data package to Singapore’s Health Sciences Authority for regulatory approval
- Planned launch in Singapore in Q4 2026
◆ Funding rounds
◆ Explore the market
◆ FAQ
What does Bioactivx do?
Singaporean biomaterial platform that makes synthetic skin substitutes for safer, faster, and scar-free wound healing.
Where is Bioactivx based?
Bioactivx is based in Singapore, Singapore, founded in 2023.
How much has Bioactivx raised?
Bioactivx has raised $3M in tracked funding and is currently at the seed stage.
Who has invested in Bioactivx?
Investors in Bioactivx include Cocoon Capital and Martin Krupp.